primary prevention

A few years ago we profiled a meta-analysis in The Lancet that supported the notion that even healthy adults could benefit from taking statin drugs (which lower LDL or 'bad' cholesterol). The benefit for the people studied was the reduction in the risk of cardiovascular events such as health attack or stroke. Since then, more studies have investigated this use of statins for so-called primary prevention, and the United States Preventive Services Task Force (USPSTF) has reviewed the data and agreed that this use of statins is valid for certain adults. Their recommendations are presented...

 

“An aspirin a day keeps the doctor away” has been the mantra for prevention of cardiovascular disease (CVD) since the early 2000s, but that seems to be changing in some cases.

It is well documented that taking aspirin helps prevent the recurrence of heart attack, stroke, and other vascular events after they have already occurred - known as “secondary prevention”.  But there is debate over the benefits of taking aspirin in people without a history of prior cardiovascular disease - primary prevention.  The current consensus advocates using low-dose aspirin, for primary prevention, in certain high risk groups: those with advanced age, diabetes, high cholesterol, high blood pressure, smoking etc.  Not so, says a new ...

5-lipitor-tabletThe current JAMA s Clinical Evidence Synopsis, and an accompanying editorial, strongly suggest what may amount to a sea-change in approaching prevention of the western world s leading killer, cardiovascular disease (CVD): heart attacks and strokes.

Dr. Fiona Taylor of the London School of Hygiene, and her colleagues affiliated with the Cochrane Database, published a meta-analysis...